Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

FXHvsBMEDETF Comparison

ETF 1
FXH

First Trust Health Care AlphaDEX Fund ETF

This fund is part of
US Health Care
+1.06%
VS
ETF 2
BMED

iShares Health Innovation Active ETF

This fund is part of
Healthcare Technology
+0.36%

First Trust Health Care AlphaDEX Fund ETF (FXH) belongs to the US Health Care segment. iShares Health Innovation Active ETF (BMED) is part of the Healthcare Technology segment. FXH's top 1 sector exposures are Healthcare. In contrast, BMED's top sector exposures are Healthcare and Non-Corporate. FXH is less expensive with a Total Expense Ratio (TER) of 0.61%, versus 0.77% for BMED. FXH is up 13.05% year-to-date (YTD) with +$32M in YTD flows. BMED performs worse with 3.8% YTD performance, and +$4M in YTD flows. Run a side-by-side ETF comparison of FXH and BMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

FXH vs BMED performance and flow charts

Performance

-4.0-3.0-2.0-1.00.01.02.0%Jul 6Jul 13Jul 20Jul 27Aug 3

Cumulative Flows

010,000,00020,000,00030,000,00040,000,00050,000,00060,000,000Jul 6Jul 13Jul 20Jul 27Aug 3

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 08/05/2026
1M3MYTD1Y3Y5Y
Perf.
FXH
BMED
+2.11%-0.21%
+13.64%+11.73%
+13.05%+3.80%
+29.01%+25.83%
+23.93%+31.59%
+6.09%+3.92%
Flows
FXH
BMED
+$57M-
+$88M-
+$32M+$4M
+$1M+$6M
-$594M+$4M
-$457M+$5M
Volatility and drawdown
3M1Y3Y5Y
Volatility
FXH
BMED
+15.87%+17.38%
+15.83%+16.02%
+15.52%+16.08%
+16.88%+17.71%
Max drawdown
FXH
BMED
-3.81%-4.62%
-12.07%-14.71%
-17.66%-19.76%
-29.40%-33.96%
Max drawdown duration
FXH
BMED
20d31d
168d195d
395d237d
1759d1586d
Trading data

Create an account to view trading data

Join for free
FXH
BMED
Last sale
8/6/2026 at 4:25 PM
$127.61
$31.35
Previous close
08/05/2026
$128.30
$31.21
Consolidated volume
08/05/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of July 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

BMED
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
FXH
BMED
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 8/6/2026 at 4:25 PM
Live
Closed
FXH
BMED
Last price
$127.61
$31.35
1D performance
-0.54%
+0.43%
AuM$1.08 B$11.29 M
E/R0.61%0.77%
Characteristics
FXH
BMED
Management strategyPassiveActive
ProviderFirst TrustiShares
BenchmarkStrataQuant Health Care Index-
N° of holdings7552
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateMay 8, 2007September 29, 2020
ESGNoNo
Advertisement
Exposure

Countries

FXH
USA
96.02%
Other
3.98%
BMED
USA
88.93%
Other
11.07%

Sectors

FXH
Healthcare
99.85%
Other
0.15%
BMED
Healthcare
97.21%
Other
2.79%
Advertisement

Diversification

FXH

Total weight of top 15 holdings out of 15

38.89%
BMED

Total weight of top 15 holdings out of 15

59.83%

Top 15 holdings

Data as of June 30, 2026
FXH
Humana, Inc.
4.74%
Organon & Co.
3.63%
DaVita, Inc.
2.98%
Elevance Health, Inc.
2.86%
Molina Healthcare, Inc.
2.80%
Exelixis, Inc.
2.53%
Incyte Corp.
2.43%
Solventum Corp.
2.41%
Biogen, Inc.
2.30%
Cardinal Health, Inc.
2.26%
Bio-Rad Laboratories, Inc.
2.14%
The Cigna Group
2.09%
Chemed Corp.
2.05%
Zimmer Biomet Holdings, Inc.
1.87%
Illumina, Inc.
1.80%
BMED
Merck & Co., Inc.
5.90%
Johnson & Johnson
5.13%
Gilead Sciences, Inc.
4.77%
Edwards Lifesciences Corp.
4.70%
BlackRock Cash Funds - Treasury
4.08%
Biogen, Inc.
3.79%
Moderna, Inc.
3.78%
Thermo Fisher Scientific, Inc.
3.69%
Charles River Laboratories International, Inc.
3.67%
Danaher Corp.
3.59%
Waters Corp.
3.52%
AbbVie, Inc.
3.49%
Amgen, Inc.
3.44%
Mettler-Toledo International, Inc.
3.17%
Vertex Pharmaceuticals, Inc.
3.11%
Frequently asked questions about FXH and BMED

How have the FXH and BMED ETFs performed in 2026?

As of August 5, 2026, FXH is up 13.05% year-to-date (YTD), while BMED has returned 3.8%. That puts FXH better performer ahead so far this year.

Which ETF is attracting more investor money: FXH or BMED?

Year-to-date, the FXH ETF saw +$32M in flows, compared to +$4M for BMED.

Which ETF is more volatile: FXH or BMED?

Over the past year, FXH had a volatility of 15.83%, while BMED experienced 16.02%.

Which ETF is bigger: FXH or BMED?

As of August 5, 2026, FXH holds $1.08 B in assets under management (AUM), while BMED manages $11.29 M.

What sectors do the FXH and BMED ETFs invest in?

FXH leans toward sectors like Healthcare. Meanwhile, BMED focuses on Healthcare.

What are the top holdings of the FXH ETF and BMED ETF?

FXH top holdings include Humana, Inc., Organon & Co. and DaVita, Inc.. BMED holds in its top three: Merck & Co., Inc., Johnson & Johnson and Gilead Sciences, Inc..

Which ETF is more diversified: FXH or BMED?

FXH holds 75 securities with 38.89% of its assets in the top 15. BMED has 55 securities and a top 15 weight of 59.83%.

Advertisement
Advertisement
Advertisement
Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.

Global ETF Survey 2026